Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss: Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT)

BACKGROUND: Systemic glucocorticosteroids (“steroids”) are widely used worldwide as a standard of care for primary therapy of idiopathic sudden sensorineural hearing loss (ISSHL). The German ISSHL guideline recommends high-dose steroids without evidence from randomized controlled trials (RCTs) and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Plontke, Stefan K., Girndt, Matthias, Meisner, Christoph, Böselt, Iris, Ludwig-Kraus, Beatrice, Richter, Michael, Rahne, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208545/
https://www.ncbi.nlm.nih.gov/pubmed/35725822
http://dx.doi.org/10.1007/s00106-022-01184-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208545/
https://www.ncbi.nlm.nih.gov/pubmed/35725822
http://dx.doi.org/10.1007/s00106-022-01184-8

Ejemplares similares